This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jun 28;356(26):2732-3.

doi: 10.1056/NEJMe078079.

Teratogenicity of SSRIs--serious concern or much ado about little?

Michael F Greene

PMID: 17596609
DOI: 10.1056/NEJMe078079

Editorial

Teratogenicity of SSRIs--serious concern or much ado about little?

Michael F Greene. N Engl J Med. 2007.

. 2007 Jun 28;356(26):2732-3.

doi: 10.1056/NEJMe078079.

Author

Michael F Greene

PMID: 17596609
DOI: 10.1056/NEJMe078079

No abstract available

PubMed Disclaimer

Comment on

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Louik C, et al. N Engl J Med. 2007 Jun 28;356(26):2675-83. doi: 10.1056/NEJMoa067407. N Engl J Med. 2007. PMID: 17596601
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study. Alwan S, et al. N Engl J Med. 2007 Jun 28;356(26):2684-92. doi: 10.1056/NEJMoa066584. N Engl J Med. 2007. PMID: 17596602

Similar articles

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study. Alwan S, et al. N Engl J Med. 2007 Jun 28;356(26):2684-92. doi: 10.1056/NEJMoa066584. N Engl J Med. 2007. PMID: 17596602
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Louik C, et al. N Engl J Med. 2007 Jun 28;356(26):2675-83. doi: 10.1056/NEJMoa067407. N Engl J Med. 2007. PMID: 17596601
SSRIs and heart defects in neonates.
Klinger G, Merlob P. Klinger G, et al. BMJ. 2009 Oct 21;339:b4288. doi: 10.1136/bmj.b4288. BMJ. 2009. PMID: 19846494 No abstract available.
Selective serotonin reuptake inhibitors and malformations: case closed?
Koren G, Nordeng HM. Koren G, et al. Semin Fetal Neonatal Med. 2013 Feb;18(1):19-22. doi: 10.1016/j.siny.2012.10.004. Epub 2012 Nov 24. Semin Fetal Neonatal Med. 2013. PMID: 23228547 Review.
[Selective serotonin reuptake inhibitors (SSRIs) in pregnancy].
Tango R, Berney P, Schulz P. Tango R, et al. Rev Med Suisse. 2006 Apr 12;2(61):981-5. Rev Med Suisse. 2006. PMID: 16686331 Review. French.

See all similar articles

Cited by

Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.
Gils C, Pottegård A, Ennis ZN, Damkier P. Gils C, et al. BMC Pregnancy Childbirth. 2016 Aug 17;16:226. doi: 10.1186/s12884-016-1025-6. BMC Pregnancy Childbirth. 2016. PMID: 27531162 Free PMC article.
Cardiac Outcomes After Perinatal Sertraline Exposure in Mice.
Haskell SE, Lo C, Kent ME, Eggleston TM, Volk KA, Reinking BE, Roghair RD. Haskell SE, et al. J Cardiovasc Pharmacol. 2017 Aug;70(2):119-127. doi: 10.1097/FJC.0000000000000501. J Cardiovasc Pharmacol. 2017. PMID: 28459713 Free PMC article.
Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.
Li Y, Cooper A, Odibo IN, Ahmed A, Murphy P, Koonce R, Dajani NK, Lowery CL, Roberts DJ, Maroteaux L, Kilic F. Li Y, et al. J Biol Chem. 2016 Apr 29;291(18):9657-65. doi: 10.1074/jbc.M116.713693. Epub 2016 Feb 26. J Biol Chem. 2016. Retraction in: J Biol Chem. 2019 Jun 14;294(24):9656. doi: 10.1074/jbc.W119.009465. PMID: 26921319 Free PMC article. Retracted. Clinical Trial.
Antidepressant use during pregnancy and risk of adverse neonatal outcomes: A comprehensive investigation of previously identified associations.
Rommel AS, Momen NC, Molenaar NM, Agerbo E, Bergink V, Munk-Olsen T, Liu X. Rommel AS, et al. Acta Psychiatr Scand. 2022 Jun;145(6):544-556. doi: 10.1111/acps.13409. Epub 2022 Feb 18. Acta Psychiatr Scand. 2022. PMID: 35152413 Free PMC article.
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.
Noorlander CW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP. Noorlander CW, et al. PLoS One. 2008 Jul 23;3(7):e2782. doi: 10.1371/journal.pone.0002782. PLoS One. 2008. PMID: 18716672 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information